You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

soluble receptor for Advanced Glycation end products

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Foot Ulcer, Diabetic Foot Trial in Parnaíba (LG1 (LLLT group 1), LG2 (LLLT group 2), LG3 (LLLT group 3))

Recruiting
  • Diabetic Foot Ulcer
  • Diabetic Foot
  • LG1 (LLLT group 1)
  • +4 more
  • Parnaíba, Piaui, Brazil
    Federal University of Piaui
Jul 25, 2022

Metastatic Pancreatic Cancer Trial in Fairhaven, Providence (FOLFOXA)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • Fairhaven, Massachusetts
  • +1 more
Jul 27, 2022

Esophageal Cancer Trial in Beijing (AN0025)

Not yet recruiting
  • Esophageal Cancer
  • Beijing, China
    Chinese PLA General Hospital
Jan 11, 2022

Submassive Pulmonary Embolism Trial in Germany, Switzerland (EkoSonic Endovascular System, Unfractionated heparin)

Completed
Has Results
  • Submassive Pulmonary Embolism
  • EkoSonic Endovascular System
  • Unfractionated heparin
  • Detmold, Germany
  • +9 more
Jul 15, 2021

Ovarian Cancer Recurrent Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion)

Recruiting
  • Ovarian Cancer Recurrent
  • microtransplantation, HLA-mismatched donor peripheral stem cell infusion
  • Beijing, Beijing, China
    The third medical center of PLA General Hospital
Oct 26, 2021

Urothelial Carcinoma, Bladder Cancer, Transitional Cell Carcinoma Trial in United States (nab-paclitaxel, Gemcitabine)

Terminated
Has Results
  • Urothelial Carcinoma
  • +2 more
  • Fort Myers, Florida
  • +4 more
Dec 15, 2021

Gastric Cancer Trial in Seoul (Pembrolizumab)

Recruiting
  • Gastric Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Dec 23, 2021

Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

Completed
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Hannover, Germany
    Medizinische Hochschule Hannover
Jan 18, 2023

CAR, Acute Myeloid Leukemia Trial in Hefei (Chimeric antigen receptor T cells (car-t))

Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • Chimeric antigen receptor T cells (car-t)
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Mar 4, 2021

Hepatocellular Carcinoma Trial in Nanning (Transarterial chemoembolization, Radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial chemoembolization
  • Radiotherapy
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 25, 2023

Cancer Metastatic, Metastatic Solid Tumor Trial (Zeaxanthin, Zeaxanthin Plus Pembrolizumab)

Not yet recruiting
  • Cancer Metastatic
  • Metastatic Solid Tumor
  • Zeaxanthin
  • Zeaxanthin Plus Pembrolizumab
  • (no location specified)
Feb 8, 2022

Advanced Breast Cancer, Anxiety, CBD Trial in Boston (Cannabidiol, Placebo)

Recruiting
  • Advanced Breast Cancer
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Feb 2, 2022

Advanced MR Imaging in Sarcoma Patients

Completed
  • Sarcoma
    • Rochester, Minnesota
      Mayo Clinic
    Feb 11, 2022

    Solid Tumor, NSCLC, Head Neck Cancer Trial in China (MCLA-129)

    Recruiting
    • Solid Tumor
    • +3 more
    • Baoding, China
    • +63 more
    Dec 19, 2021

    Cancer, Liver Dysfunction Trial in Singapore (TS-1 combined with cisplatin)

    Recruiting
    • Cancer
    • Liver Dysfunction
    • TS-1 combined with cisplatin
    • Singapore, Singapore
    • +1 more
    Apr 12, 2022

    Pancreatic Adenocarcinoma Trial in Louisville (Nivolumab, Irreversible Electroporation)

    Active, not recruiting
    • Pancreatic Adenocarcinoma
    • Louisville, Kentucky
      University of Louisville
    Oct 6, 2021

    Anemia Trial in New York (Ferumoxytol injection)

    Recruiting
    • Anemia
    • Ferumoxytol injection
    • New York, New York
      NYU Langone Health
    Aug 11, 2022

    Urothelial Carcinoma Associated 1 RNA, Human Trial (Pembrolizumab, Cisplatin, Carboplatin)

    Active, not recruiting
    Has Results
    • Urothelial Carcinoma Associated 1 RNA, Human
    • Pembrolizumab
    • +3 more
    • (no location specified)
    Aug 18, 2022

    Urothelial Cancer Trial (pembrolizumab)

    Completed
    Has Results
    • Urothelial Cancer
    • pembrolizumab
    • (no location specified)
    Aug 18, 2022

    Fistula-associated Anal Adenocarcinoma

    Completed
    • Rectal Cancer
      • (no location specified)
      May 14, 2022

      Brain Metabolic Network of PET in Advanced Non-Small Cell Lung

      Completed
      • Advanced Non-small-cell Lung Cancer
      • None of any intervention
      • Zhuhai, Guangdong, China
        PET/CT
      May 18, 2022

      Tobacco Use Trial in Pittsburgh (Tobacco power wall size and tobacco products displayed)

      Recruiting
      • Tobacco Use
      • Tobacco power wall size and tobacco products displayed
      • Pittsburgh, Pennsylvania
        RAND
      Apr 25, 2022

      Morbid Obesity D009765 Trial in Nice, Montpellier (Omega-3 Fatty Acid, Placebo)

      Completed
      • Morbid Obesity D009765
      • Omega-3 Fatty Acid
      • Placebo
      • Nice, Alpes-maritimes, France
      • +1 more
      Feb 18, 2022

      Thrombosis, Blood Coagulation Disorder, Platelet Thrombus Trial in Milano (PAS assay, TGT)

      Recruiting
      • Thrombosis
      • +4 more
      • PAS assay, TGT
      • Milano, MI, Italy
        San Raffaele Scientifc Institute - Cardiothoracic Intensive Care
      May 4, 2022

      Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, paclitaxel)

      Completed
      Has Results
      • Gastric Adenocarcinoma
      • Gastroesophageal Junction Adenocarcinoma
      • (no location specified)
      May 12, 2022